Table 2.
Characteristic clinical manifestation of thymomas and differential diagnosis with other causes of mediastinal masses
|
|
Speed of development
|
Associated clinical manifestations
|
Characteristic signs
|
| Thymoma | Long course or indolent | Compressive symptoms: Chest pain, dyspnea, dysphagia, vena cava syndrome | Laboratory abnormalities: Anti-acetylcholine receptor antibodies (common if associated with MG), hypogammaglobulinemia, erythropenia, pancytopenia |
| Neurological autoimmune disorders: MG, myotonic dystrophy, limbic encephalitis, peripheral neuropathy | |||
| Hematologic autoimmune disorders: Red-cell aplasia, pernicious anemia, erythrocytosis, pancytopenia | |||
| Thymic carcinoma | Rapid growth | Collagen autoimmune disorders: Systemic lupus erythematosus, rheumatoid arthritis, Sjogren's syndrome, scleroderma | PET-CT: Thymoma types A, AB, B1-2: Low uptake. |
| Endocrine disorders: Multiple endocrine neoplasia, Cushing's syndrome, thyroiditis | PET-CT: Type B3 thymoma and thymic carcinoma: High uptake, with loss of bilobar structure of the thymus | ||
| Autoimmune deficiencies: Hypogammaglobulinemia, T-cell deficiency | |||
| Lymphoma | Fulminant onset | Dermatological disorders: Pemphigus, Lichen planus | Elevated LDH |
| “B” symptoms: Fever, weight loss, sweating | |||
| Teratoma | Slow development | Lymphadenopathy. Asymptomatic or compressive symptoms of long duration | CT: Heterogeneous mass, with cystic component and fat/calcifications |
| Germ cell tumors | Rapid development | Testicular mass | Seminoma: Elevated beta-HCG |
| No seminoma: Elevated beta-HCG and AFP | |||
| Thymic hyperplasia | Indolent | Asymptomatic | PET-CT: Elevated uptake in mass that maintains the thymic bilobar structure |
MG: Myasthenia gravis; PET-CT: Positron emission tomography-computed tomography; LDH: Lactate dehydrogenase; HCG: Human chorionic gonadotropin; AFP: Alpha fetoprotein.